Works by Bakris, George L.


Results: 317
    1
    2

    Design and Baseline Characteristics of the Finerenone in Reducing Kidney Failure and Disease Progression in Diabetic Kidney Disease Trial.

    Published in:
    2019
    By:
    • Bakris, George L.;
    • Agarwal, Rajiv;
    • Anker, Stefan D.;
    • Pitt, Bertram;
    • Ruilope, Luis M.;
    • Nowack, Christina;
    • Kolkhof, Peter;
    • Ferreira, Anna C.;
    • Schloemer, Patrick;
    • Filippatos, Gerasimos;
    • Bakris, George L;
    • Anker, Stefan D;
    • Ruilope, Luis M;
    • Ferreira, Anna C;
    • on behalf of the FIDELIO-DKD study investigators;
    • FIDELIO-DKD study investigators
    Publication type:
    journal article
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21

    Front Cover.

    Published in:
    Diabetes, Obesity & Metabolism, 2024, v. 26, n. 1, p. C1, doi. 10.1111/dom.15423
    By:
    • Perakakis, Nikolaos;
    • Bornstein, Stefan R.;
    • Birkenfeld, Andreas L.;
    • Linkermann, Andreas;
    • Demir, Münevver;
    • Anker, Stefan D.;
    • Filippatos, Gerasimos;
    • Pitt, Bertram;
    • Rossing, Peter;
    • Ruilope, Luis M.;
    • Kolkhof, Peter;
    • Lawatscheck, Robert;
    • Scott, Charlie;
    • Bakris, George L.
    Publication type:
    Article
    22

    Efficacy of finerenone in patients with type 2 diabetes, chronic kidney disease and altered markers of liver steatosis and fibrosis: A FIDELITY subgroup analysis.

    Published in:
    Diabetes, Obesity & Metabolism, 2024, v. 26, n. 1, p. 191, doi. 10.1111/dom.15305
    By:
    • Perakakis, Nikolaos;
    • Bornstein, Stefan R.;
    • Birkenfeld, Andreas L.;
    • Linkermann, Andreas;
    • Demir, Münevver;
    • Anker, Stefan D.;
    • Filippatos, Gerasimos;
    • Pitt, Bertram;
    • Rossing, Peter;
    • Ruilope, Luis M.;
    • Kolkhof, Peter;
    • Lawatscheck, Robert;
    • Scott, Charlie;
    • Bakris, George L.
    Publication type:
    Article
    23

    Back Cover.

    Published in:
    Diabetes, Obesity & Metabolism, 2023, v. 25, n. 10, p. C4, doi. 10.1111/dom.15286
    By:
    • Rossing, Peter;
    • Anker, Stefan D.;
    • Filippatos, Gerasimos;
    • Pitt, Bertram;
    • Ruilope, Luis M.;
    • Billings, Liana K.;
    • Green, Jennifer B.;
    • Koya, Daisuke;
    • Mosenzon, Ofri;
    • Pantalone, Kevin M.;
    • Ahlers, Christiane;
    • Lage, Andrea;
    • Lawatscheck, Robert;
    • Scalise, Andrea;
    • Bakris, George L.
    Publication type:
    Article
    24

    The impact of obesity on cardiovascular and kidney outcomes in patients with chronic kidney disease and type 2 diabetes treated with finerenone: Post hoc analysis of the FIDELITY study.

    Published in:
    Diabetes, Obesity & Metabolism, 2023, v. 25, n. 10, p. 2989, doi. 10.1111/dom.15197
    By:
    • Rossing, Peter;
    • Anker, Stefan D.;
    • Filippatos, Gerasimos;
    • Pitt, Bertram;
    • Ruilope, Luis M.;
    • Billings, Liana K.;
    • Green, Jennifer B.;
    • Koya, Daisuke;
    • Mosenzon, Ofri;
    • Pantalone, Kevin M.;
    • Ahlers, Christiane;
    • Lage, Andrea;
    • Lawatscheck, Robert;
    • Scalise, Andrea;
    • Bakris, George L.
    Publication type:
    Article
    25

    Cover Image.

    Published in:
    Diabetes, Obesity & Metabolism, 2023, v. 25, n. 6, p. 1, doi. 10.1111/dom.15115
    By:
    • McGill, Janet B.;
    • Agarwal, Rajiv;
    • Anker, Stefan D.;
    • Bakris, George L.;
    • Filippatos, Gerasimos;
    • Pitt, Bertram;
    • Ruilope, Luis M.;
    • Birkenfeld, Andreas L.;
    • Caramori, Maria L.;
    • Brinker, Meike;
    • Joseph, Amer;
    • Lage, Andrea;
    • Lawatscheck, Robert;
    • Scott, Charlie;
    • Rossing, Peter
    Publication type:
    Article
    26

    Effects of finerenone in people with chronic kidney disease and type 2 diabetes are independent of HbA1c at baseline, HbA1c variability, diabetes duration and insulin use at baseline.

    Published in:
    Diabetes, Obesity & Metabolism, 2023, v. 25, n. 6, p. 1512, doi. 10.1111/dom.14999
    By:
    • McGill, Janet B.;
    • Agarwal, Rajiv;
    • Anker, Stefan D.;
    • Bakris, George L.;
    • Filippatos, Gerasimos;
    • Pitt, Bertram;
    • Ruilope, Luis M.;
    • Birkenfeld, Andreas L.;
    • Caramori, Maria L.;
    • Brinker, Meike;
    • Joseph, Amer;
    • Lage, Andrea;
    • Lawatscheck, Robert;
    • Scott, Charlie;
    • Rossing, Peter
    Publication type:
    Article
    27
    28

    Front Cover.

    Published in:
    Diabetes, Obesity & Metabolism, 2023, v. 25, n. 2, p. C1, doi. 10.1111/dom.14960
    By:
    • Rossing, Peter;
    • Agarwal, Rajiv;
    • Anker, Stefan D.;
    • Filippatos, Gerasimos;
    • Pitt, Bertram;
    • Ruilope, Luis M.;
    • Fonseca, Vivian;
    • Umpierrez, Guillermo E.;
    • Caramori, Maria Luiza;
    • Joseph, Amer;
    • Lambelet, Marc;
    • Lawatscheck, Robert;
    • Bakris, George L.
    Publication type:
    Article
    29
    30
    31
    32
    33
    34
    35

    High‐sensitivity C‐reactive protein, low‐density lipoprotein cholesterol and cardiovascular outcomes in patients with type 2 diabetes in the EXAMINE (Examination of Cardiovascular Outcomes with Alogliptin versus Standard of Care) trial.

    Published in:
    Diabetes, Obesity & Metabolism, 2018, v. 20, n. 3, p. 654, doi. 10.1111/dom.13136
    By:
    • Hwang, You‐cheol;
    • Morrow, David A.;
    • Cannon, Christopher P.;
    • Liu, Yuyin;
    • Bergenstal, Richard;
    • Heller, Simon;
    • Mehta, Cyrus;
    • Cushman, William;
    • Bakris, George L.;
    • Zannad, Faiez;
    • White, William B.
    Publication type:
    Article
    36

    Relationship of glycated haemoglobin and reported hypoglycaemia to cardiovascular outcomes in patients with type 2 diabetes and recent acute coronary syndrome events: The EXAMINE trial.

    Published in:
    Diabetes, Obesity & Metabolism, 2017, v. 19, n. 5, p. 664, doi. 10.1111/dom.12871
    By:
    • Heller, Simon R.;
    • Bergenstal, Richard M.;
    • White, William B.;
    • Kupfer, Stuart;
    • Bakris, George L.;
    • Cushman, William C.;
    • Mehta, Cyrus R.;
    • Nissen, Steven E.;
    • Wilson, Craig A.;
    • Zannad, Faiez;
    • Liu, Yuyin;
    • Gourlie, Noah M.;
    • Cannon, Christopher P.
    Publication type:
    Article
    37
    38
    39

    Impact of Finerenone-Induced Albuminuria Reduction on Chronic Kidney Disease Outcomes in Type 2 Diabetes: A Mediation Analysis.

    Published in:
    Annals of Internal Medicine, 2023, v. 176, n. 12, p. 1606, doi. 10.7326/M23-1023
    By:
    • Agarwal, Rajiv;
    • Tu, Wanzhu;
    • Farjat, Alfredo E.;
    • Farag, Youssef M.K.;
    • Toto, Robert;
    • Kaul, Sanjay;
    • Lawatscheck, Robert;
    • Rohwedder, Katja;
    • Ruilope, Luis M.;
    • Rossing, Peter;
    • Pitt, Bertram;
    • Filippatos, Gerasimos;
    • Anker, Stefan D.;
    • Bakris, George L.;
    • Vallejos, Augusto;
    • MacIsaac, Richard;
    • Schernthaner, Guntram;
    • Gillard, Pieter;
    • Canziani, Maria Eugenia F.;
    • Temelkova-Kurktschiev, Theodora
    Publication type:
    Article
    40
    41

    Mineralocorticoid receptor antagonists for heart failure with reduced ejection fraction: integrating evidence into clinical practice.

    Published in:
    European Heart Journal, 2012, v. 33, n. 22, p. 2782, doi. 10.1093/eurheartj/ehs257
    By:
    • Zannad, Faiez;
    • Gattis Stough, Wendy;
    • Rossignol, Patrick;
    • Bauersachs, Johann;
    • McMurray, John J.V.;
    • Swedberg, Karl;
    • Struthers, Allan D.;
    • Voors, Adriaan A.;
    • Ruilope, Luis M.;
    • Bakris, George L.;
    • O'Connor, Christopher M.;
    • Gheorghiade, Mihai;
    • Mentz, Robert J.;
    • Cohen-Solal, Alain;
    • Maggioni, Aldo P.;
    • Beygui, Farzin;
    • Filippatos, Gerasimos S.;
    • Massy, Ziad A.;
    • Pathak, Atul;
    • Piña, Ileana L.
    Publication type:
    Article
    42
    43

    Organic Anion Transporter Gene Variants Associated With Plasma Exposure and Long‐Term Response to Atrasentan in Patients With Diabetic Kidney Disease.

    Published in:
    Clinical Pharmacology & Therapeutics, 2022, v. 112, n. 5, p. 1098, doi. 10.1002/cpt.2721
    By:
    • Smeijer, J. David;
    • Koomen, Jeroen V.;
    • Kohan, Donald E.;
    • McMurray, John J. V.;
    • Bakris, George L.;
    • Correa‐Rotter, Ricardo;
    • Hou, Fan‐Fan;
    • Kitzman, Dalane W.;
    • Makino, Hirofumi;
    • Mayer, Gert;
    • Nowicki, Michal;
    • Perkovic, Vlado;
    • Rossing, Peter;
    • Tobe, Sheldon;
    • Parving, Hans‐Henrik;
    • de Zeeuw, Dick;
    • Heerspink, Hiddo J. L.
    Publication type:
    Article
    44
    45
    46
    47

    Design and baseline characteristics of the Finerenone, in addition to standard of care, on the progression of kidney disease in patients with Non-Diabetic Chronic Kidney Disease (FIND-CKD) randomized trial.

    Published in:
    Nephrology Dialysis Transplantation, 2025, v. 40, n. 2, p. 308, doi. 10.1093/ndt/gfae132
    By:
    • Heerspink, Hiddo J L;
    • Agarwal, Rajiv;
    • Bakris, George L;
    • Cherney, David Z I;
    • Lam, Carolyn S P;
    • Neuen, Brendon L;
    • Sarafidis, Pantelis A;
    • Tuttle, Katherine R;
    • Wanner, Christoph;
    • Brinker, Meike D;
    • Dizayee, Sara;
    • Kolkhof, Peter;
    • Schloemer, Patrick;
    • Vesterinen, Paula;
    • Perkovic, Vlado;
    • investigators, for the FIND-CKD
    Publication type:
    Article
    48

    Kidney outcomes with finerenone: an analysis from the FIGARO-DKD study.

    Published in:
    Nephrology Dialysis Transplantation, 2023, v. 38, n. 2, p. 372, doi. 10.1093/ndt/gfac157
    By:
    • Ruilope, Luis M;
    • Pitt, Bertram;
    • Anker, Stefan D;
    • Rossing, Peter;
    • Kovesdy, Csaba P;
    • Pecoits-Filho, Roberto;
    • Pergola, Pablo;
    • Joseph, Amer;
    • Lage, Andrea;
    • Mentenich, Nicole;
    • Scheerer, Markus F;
    • Bakris, George L
    Publication type:
    Article
    49

    Effects of canagliflozin versus finerenone on cardiorenal outcomes: exploratory post hoc analyses from FIDELIO-DKD compared to reported CREDENCE results.

    Published in:
    Nephrology Dialysis Transplantation, 2022, v. 37, n. 7, p. 1261, doi. 10.1093/ndt/gfab336
    By:
    • Agarwal, Rajiv;
    • Anker, Stefan D;
    • Filippatos, Gerasimos;
    • Pitt, Bertram;
    • Rossing, Peter;
    • Ruilope, Luis M;
    • Boletis, John;
    • Toto, Robert;
    • Umpierrez, Guillermo E;
    • Wanner, Christoph;
    • Wada, Takashi;
    • Scott, Charlie;
    • Joseph, Amer;
    • Ogbaa, Ike;
    • Roberts, Luke;
    • Scheerer, Markus F;
    • Bakris, George L
    Publication type:
    Article
    50

    Baseline characteristics in the Bardoxolone methyl EvAluation in patients with Chronic kidney disease and type 2 diabetes mellitus: the Occurrence of renal eveNts (BEACON) trial.

    Published in:
    Nephrology Dialysis Transplantation, 2013, v. 28, n. 11, p. 2841, doi. 10.1093/ndt/gft445
    By:
    • Lambers Heerspink, Hiddo J.;
    • Chertow, Glenn M.;
    • Akizawa, Tadao;
    • Audhya, Paul;
    • Bakris, George L.;
    • Goldsberry, Angie;
    • Krauth, Melissa;
    • Linde, Peter;
    • McMurray, John J.;
    • Meyer, Colin J.;
    • Parving, Hans-Henrik;
    • Remuzzi, Giuseppe;
    • Christ-Schmidt, Heidi;
    • Toto, Robert D.;
    • Vaziri, Nosratola D.;
    • Wanner, Christoph;
    • Wittes, Janet;
    • Wrolstad, Danielle;
    • de Zeeuw, Dick
    Publication type:
    Article